Francesco Novelli
Turin, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 84 publications
The H63D Polymorphism in the HFE Gene Promotes Aggressive Disease Phenotypes in Pancreatic Ductal Adenocarcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 15, 2026
The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenocarcinoma.
Journal: Clinical and translational medicine
Published: April 08, 2025
Fighting Pancreatic Cancer with a Vaccine-Based Winning Combination: Hope or Reality?
Journal: Cells
Published: August 08, 2024
In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigens.
Journal: Frontiers in immunology
Published: May 03, 2024
PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 21, 2024
Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer patient survival.
Journal: Clinical and experimental medicine
Published: July 10, 2023
A neuroligin-2-YAP axis regulates progression of pancreatic intraepithelial neoplasia.
Journal: EMBO reports
Published: June 05, 2023
IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer.
Journal: Nature
Published: December 12, 2022
Exploring chitosan-shelled nanobubbles to improve HER2 + immunotherapy via dendritic cell targeting.
Exploring chitosan-shelled nanobubbles to improve HER2 + immunotherapy via dendritic cell targeting.
Journal: Drug delivery and translational research
Published: May 16, 2022
Last Updated: 09/26/2026